6 days ago · The Food and Drug Administration has approved Ozempic ® (semaglutide) to reduce the risk of sustained estimated glomerular filtration rate (eGFR) decline, end-stage …

Jan 28, 2025 · The F.D.A. based its decision to expand the approved uses of Ozempic on research showing that people with Type 2 diabetes and chronic kidney disease who took the …

May 24, 2024 · Semaglutide reduced the risk of clinically important kidney outcomes and death from cardiovascular causes in patients with type 2 diabetes and chronic kidney disease.

Jan. 29, 2025 -- The FDA has approved Novo Nordisk's diabetes drug Ozempic to help reduce the risk of worsening kidney disease, kidney failure, and heart-related death in adults with type …

How Ozempic helps manage chronic kidney disease . Results of the FLOW trial showed a reduction in glucose and A1C levels, as well as some evidence for reductions in lipid values, …

Feb 3, 2025 · FDA approves Ozempic ® (semaglutide) as the only GLP-1 RA to reduce the risk of worsening kidney disease and cardiovascular death in adults with type 2 diabetes and chronic …

Jan 28, 2025 · Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the US Food and Drug Administration to reduce …

Nov 6, 2024 · The research on Ozempic shows that it may help protect kidney function in people with obesity and heart disease risk factors. This effect may be seen in people with or without …

Jul 26, 2024 · Research has found a connection between semaglutide, Ozempic’s main active ingredient, and the condition. Here’s what’s behind it. What is Ozempic? Can Ozempic help …

May 24, 2024 · Semaglutide, the compound in the blockbuster drugs Ozempic and Wegovy, dramatically reduced the risk of kidney complications, heart issues and death in people with …